Compare RYTM & YOU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYTM | YOU |
|---|---|---|
| Founded | 2008 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.2B |
| IPO Year | 2017 | 2021 |
| Metric | RYTM | YOU |
|---|---|---|
| Price | $82.62 | $54.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 7 |
| Target Price | ★ $131.14 | $50.29 |
| AVG Volume (30 Days) | 505.0K | ★ 1.3M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.50% |
| EPS Growth | ★ 28.34 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $900,779,000.00 |
| Revenue This Year | $55.34 | $17.56 |
| Revenue Next Year | $86.06 | $14.73 |
| P/E Ratio | ★ N/A | $20.59 |
| Revenue Growth | N/A | ★ 16.91 |
| 52 Week Low | $55.31 | $23.90 |
| 52 Week High | $122.20 | $59.52 |
| Indicator | RYTM | YOU |
|---|---|---|
| Relative Strength Index (RSI) | 39.88 | 57.87 |
| Support Level | $74.50 | $45.31 |
| Resistance Level | $90.79 | $55.64 |
| Average True Range (ATR) | 3.24 | 2.44 |
| MACD | -0.28 | -0.24 |
| Stochastic Oscillator | 23.60 | 58.17 |
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.
Clear Secure Inc is an identity company making experiences safer and easier digitally and physically. It is involved in creating a frictionless travel experience while enhancing security. Its secure identity platform uses biometrics to automate the identity verification process through lanes in airports, helping to make the travel experience safe and easy. The Company's operations are mainly focused on growing and maintaining its secure identity network across multiple offerings in both aviation and non-aviation channels.